Sponsor Pipeline

Qingdao Sino-Cell Biomedicine Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
1
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1
3
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07406724 HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma Melanoma (Excluding Uveal Melanoma) Not Yet Recruiting
Phase 1
NCT06342336 HS-IT101 Injection in the Treatment of Advanced Solid Tumors Solid Tumor Recruiting
NCT06941818 HS-IT101 Injection in the Treatment of Advanced Melanoma Advanced Melanoma Enrolling by Invitation
NCT07105176 HS-IT101 Injection for Advanced NSCLC Advanced Non-Small Cell Lung Cancer Not Yet Recruiting
Early Phase 1
NCT06613152 HS-IT201 Injection in the Treatment of Advanced Solid Tumors Solid Tumor Not Yet Recruiting
Disease Areas
Get alerts when Qingdao Sino-Cell Biomedicine Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free